Abstract
Negative affect appears frequently in rheumatic diseases, but studies about their importance and prevalence in systemic sclerosis patients are scarce, and the results are inconclusive separately. We conducted a comprehensive search on April 2013 of PubMed, Medline, and PsycINFO databases to identify original research studies published. A total of 48 studies were included in this systematic review. We found negative emotions have very high levels in these patients, compared to both healthy population other chronic rheumatic patients assessed with the same instruments and cutoffs. Depression has been, of the three negative emotions that we approach to in this review, the most widely studied in systemic sclerosis, followed by anxiety. Despite the fact that anger is a common emotion in these diseases is poorly studied. Methodologic issues limited the ability to draw strong conclusions from studies of predictors. Disease-specific symptoms (swollen joints, gastrointestinal and respiratory symptoms and digital ulcers) and factors related to physical appearance were associated with negative emotions. Interdisciplinary care and biopsychosocial approach would have a great benefit in the clinical management of these patients.
Similar content being viewed by others
References
Wilson IB, Cleary PD (1995) Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. J Am Med Assoc 273:59–65
Consedine NS, Magai C, Cohen CI, Gilespie M (2002) Ethnic variation in the impact of negative affect and emotion inhibition on the health of older adults. J Gerontol Ser B Psychol Sci 57B:396–408
Schulz R, Drayer RA, Rollman BL (2002) Depression as a risk factor for non-suicide mortality in the elderly. Biol Psychiatry 52:205–225
Suls J, Bunde J (2005) Anger, anxiety and depression as risk factors for cardiovascular disease: the problems and implications of overlapping affective dispositions. Psychol Bull 131:260–300
Ang DC, Choi H, Kroenke K, Wolfe F (2005) Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol 32:1013–1019
Cuijpers P, Smit H (2002) Excess mortality in depression: a meta-analysis of community studies. J Affect Disord 72:227–236
Rosemann T, Laux G, Kuehlein T (2007) Osteoarthritis and functional disability: results of a cross sectional study among primary care patients in Germany. BMC Musculoskelet Disord 8:79
Joyce AT, Smith P, Khandker R, Melin JM, Singh A (2009) Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA. J Rheumatol 36:743–752
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
Thombs BD, Fuss S, Hudson M, Schieir O, Taillefer SS, Fogel J, Ford DE, Baron M, Canadian Scleroderma Research Group (2008) High rates of depressive symptoms among patients with systemic sclerosis are not explained by differential reporting of somatic symptoms. Arthritis Rheum 59(3):431–437
Thombs BD, Hudson M, Schieir O, Taillefer SS, Baron M, Canadian Scleroderma Research Group (2008) Reliability and validity of the center for epidemiologic studies depression scale in patients with systemic sclerosis. Arthritis Rheum 59(3):438–443
Kwakkenbos L, Arthurs E, van den Hoogen FH, Hudson M, van Lankveld WG, Baron M, van den Ende CH, Thombs BD, Canadian Scleroderma Research Group (2013) Cross-language measurement equivalence of the Center for Epidemiologic Studies Depression (CES-D) scale in systemic sclerosis: a comparison of Canadian and Dutch patients. PLoS One 8(1):e53923. doi:10.1371/journal.pone.0053923
Thombs BD, Hudson M, Bassel M, Taillefer SS, Baron M, Canadian Scleroderma Research Group (2009) Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: evidence from a sample of 659 Canadian Scleroderma Research Group Registry patients. Arthritis Rheum 61(7):966–973. doi:10.1002/art.24614
Milette K, Hudson M, Baron M, Thombs BD, Canadian Scleroderma Research Group (2010) Comparison of the PHQ-9 and CES-D depression scales in systemic sclerosis: internal consistency reliability, convergent validity and clinical correlates. Rheumatology (Oxford) 49(4):789–796
Arthurs E, Steele RJ, Hudson M, Baron M, Thombs BD, (CSRG) Canadian Scleroderma Research Group (2012) Are scores on English and French versions of the PHQ-9 comparable? An assessment of differential item functioning. PLoS One 7(12):e52028. doi:10.1371/journal.pone.0052028
Beck A, Ward C, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571
Beck A (1972) Screening depressed patients in family practice: a rapid technique. Postgrad Med 56:81–85
Montgomery SA, Asberg M (1979) A new scale designed to be sensitive to change. Br J Psychiatry 134:382–389
Zung WW (1965) A self-rating depression scale. Arch Gen Psychiatry 12:63–70
Bedford A, Fould GA (1978) Delusions-symptoms-states Inventory States of Anxiety and Depression (Manual). NFER Publishing, Windsor
Derogatis LR, Covi L, Lipman RS (1973) The SCL-90: an out-patients psychiatric rating scale. Psychopharmacol Bull 9:13–28
Moss-Morris R, Weinman J, Petrie KJ, Horne R, Cameron LD, Buick D (2002) The revised Illness Perception Questionnaire (IPQ-R). Psychol Health 17:1–16
Meenan RF, Mason JH, Anderson JJ, Guccione AA, Kazis LE (1992) AIMS2: the content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis Rheum 35:1–10
Derogatis LR (1986) The Psychosocial Adjustment to Illness Scale (PAIS). J Psychosom Res 30:77–91
Hudson M, Thombs BD, Steele R, Watterson R, Taillefer S, Baron M, Canadian Scleroderma Research Group Investigators (2008) Clinical correlates of quality of life in systemic sclerosis measured with the World Health Organization Disability Assessment Schedule II. Arthritis Rheum 59(2):279–284. doi:10.1002/art.23344
Leavens A, Patten SB, Hudson M, Baron M, Thombs BD, Canadian Scleroderma Research Group (CSRG) (2012) Influence of somatic symptoms on PHQ-9 depression scores among patients with systemic sclerosis compared to a healthy general population sample. Arthritis Care Res (Hoboken). doi:10.1002/acr.21675
Roca RP, Wigley FM, White B (1996) Depressive symptoms associated with scleroderma. Arthritis Rheum 29(6):1035–1040
Benrud-Larson LM, Haythornwaite JA, Heinberg LJ, Boling C, Reed J, White B, Wigley FM (2002) The impact of pain and symptoms of depression in scleroderma. Pain 95:267–275
Matsuura E, Ohta A, Kanegae F, Haruda Y, Ushiyama O, Koarada S, Togashi R, Tada Y, Suzuki N, Nagasawa K (2003) Frecuency and analysis of factors closely associated with the development of depressive symptoms in patients with scleroderma. J Rheumatol 30(8):1782–1787
Richards HL, Herrick AL, Griffin K, Gwilliam PDH, Loukes J, Fortune DG (2003) Systemic sclerosis: patient’s perceptions of their condition. Arthritis Care Res 49(5):689–696
Benrud-Larson LM, Heinberg LJ, Boling C, Reed J, White B, Wigley FM, Haythornwaite JA (2003) Body image dissatisfaction among women with scleroderma: extent and relationship to psychosocial function. Health Psychol 22(2):130–139
Vera-Lastra O, Martinez R, Pacheco M, Medina G, Jara LJ, Ariza R (2006) Frecuency of depressive symptoms in systemic sclerosis (SSC) and treatment with flouxetine. J Clin Rheumatol 12(4 Suppl):S83
Thombs BD, Hudson M, Taillefer SS, Baron M, Canadian Scleroderma Research Group (2008) Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis. Arthritis Rheum 59(4):504–509. doi:10.1002/art.23524
Legendre C, Allanore Y, Ferrand I, Kahan A (2005) Evaluation of depression and anxiety in patients with systemic sclerosis. Joint Bone Spine 72:408–411
Nietert PJ, Mitchell HC, Bolster MB, Curran MY, Tilley BC, Silver RM (2005) Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis. J Rheumatol 32(1):51–57
Taillefer SS, Baron M, Hudson M (2005) Predictors of depressive symptoms in patients with systemic sclerosis (SSC). Ann Rheum Dis 64:925
Taillefer S, Baron M, Hudson M (2005) Disability, pain and dyspnea predict levels of depression in systemic sclerosis (SSC). Arthritis Rheum 52(9 S):1569
Khanna D, Ahmed M, Furst DE, Ginsburg SS, Park GS, Hornung R, Tsevat J (2007) Health values of patients with systemic sclerosis. Arthritis Rheum 57(1):86–93
Bodukam V, Hays RD, Maranian P, Furst DE, Seibold JR, Impens A, Mayes MD, Clements PJ, Khanna D (2011) Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis. Rheumatology 50:330–334
Ostojic P, Zivojinovic S, Reza T, Damjanov N (2010) Symptoms of depression and anxiety in Serbian patients with systemic sclerosis: impact of disease severity and socioeconomic factors. Mod Rheumatol 20(4):353–357
Mozzetta A, Antinone V, Alfani S, Neri P, Bonda PGF, Pasquini P, Puddu P, Picardi A (2008) Mental health in patients with systemic sclerosis: a controlled investigation. J Eur Acad Dermatol Venereol 22(3):336–340
Baubet T, Ranque B, Taïeb O, Bérezné A, Bricou O, Mehallel S, Moroni C, Belin C, Pagnoux C, Moro MR, Guillevin L, Mouthon L (2011) Mood and anxiety disorders in systemic sclerosis patients. Presse Med 40(2):e111–e119
Angelopoulos NV, Drosos AA, Moutsopoulos HM (2001) Psychiatric symptoms associated with scleroderma. Psychother Psychosom 70:145–150
Jewett LR, Razykov I, Hudson M, Baron M, Thombs BD, Canadian Scleroderma Research Group (2013) Prevalence of current, 12-month and lifetime major depressive disorder among patients with systemic sclerosis. Rheumatology (Oxford) 52(4):669–675. doi:10.1093/rheumatology/kes347
Wafki F, Amine B, Ibn Yacoub Y, Laatiriss A, Znat F, Abouqal R, Hajjaj-Hassouni N (2012) Depression among the Moroccan systemic sclerosis. Clin Rheumatol 31(1):73–77
Walker JG, Steele RJ, Schnitzer M, Taillefer S, Baron M, Canadian Scleroderma Research Group, Hudson M (2010) The association between disease activity and duration in systemic sclerosis. J Rheumatol 37(11):2299–2306
Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P, Korn JH, Simms RW, Csuka ME, Medsger TA, Rothfield NF, Ellman MH, Collier DH, Weinstein A, Furst DE, Jiménez SA, White B, Seibold JR, Wigley FM, For the Scleroderma Cinical Trials Consortium (2002) Measuring disease activity and functional status in patients with scleroderma and Raynaud’s phenomenon. Arthritis Rheum 46(9):2410–2420
Nietert PJ, Mitchell HC, Bolster MB, Curran MY, Silver RM (2004) How do functional status and gastrointestinal dysfunction influence depression among patients with systemic sclerosis? Arthritis Rheum 50(9):S1174
Hyphantis TN, Tsifetaki N, Pappa C, Voulgari PV, Siafaka V, Bai M, Alamanos Y, Drosos AA, Mavreas V (2007) Clinical features and personality traits associated with psychological distress in systemic sclerosis patients. J Psycosom Res 62(1):47–56
Frech T, Hays RD, Maranian P, Clements PJ, Furst DE, Khanna D (2011) Prevalence and correlates of sleep disturbance in systemic sclerosis—results from the UCLA scleroderma quality of life study. Rheumatology (Oxford) 50(7):1280–1287
Sariyildiz MA, Batmaz I, Budulgan M, Bozkurt M, Yazmalar L, Inanir A, Celepkolu T, Cevik R (2013) Sleep quality in patients with systemic sclerosis: relationship between the clinical variables, depressive symptoms, functional status, and the quality of life. Rheumatol Int (Epub ahead of print)
Benrud-Larson LM, Heinberg LJ, Boling C, Reed J, White B, Wigley FM, Haythornwaite JA (2003) Body image dissatisfaction among women with scleroderma: extent and relationship to psychosocial function. Health Psychol 22(2):130–139
Lawrence JW, Heinberg LJ, Roca R, Munster A, Spence R, Fauerbach JA (1998) Development and validation of the Satisfaction with Appearance Scale: assessing body image among burn-injured patients. Psychol Assess 10:64–70
Kwakkenbos L, van Lankveld WG, Vonk MC, Becker ES, van den Hoogen FH, van den Ende CH (2012) Disease-related and psychosocial factors associated with depressive symptoms in patients with systemic sclerosis, including fear of progression and appearance self-esteem. J Psychosom Res 72(3):199–204. doi:10.1016/j.jpsychores.2011.12.005
Malcarne VL, Hansdottir I, Greenbergs HL, Clements PJ, Weisman MH (1999) Appearance self-esteem in systemic sclerosis. Cogn Ther Res 23(2):197–208
Antonowsky A (1993) The structure and properties of the sense of coherence scale. Soc Sci Med 36:725–733
Buck U, Poole J, Mendelson C (2010) Factors related to self-efficacy in persons with scleroderma. Musculoskelet Care 8(4):197–203. doi:10.1002/msc.181
McFarlane AC, Brooks PM (1988) Determinants of disability in rheumatoid arthritis. Br J Rheumatol 27:7–14
Katz PP, Yelin EH (1993) Prevalence and correlates of depressive symptoms among persons with rheumatoid arthritis. J Rheumatol 20:790–796
Wright GE, Parker JC, Smarr KL, Schoenfeld-Smith K, Buckelew SP, Slaughter JR, Johnson JC, Hewett JE (1996) Risk factors for depression in rheumatoid arthritis. Arthritis Care Res 9:264–272
Danieli E, Airo P, Bettoni L, Cinquini M, Antonioli CM, Cavazzana I, Franceschini F, Cattaneo R (2005) Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. Clin Rheumatol 24(1):48–54
Müller H, Rehberger P, Günther C, Schmitt J (2012) Determinants of disability, quality of life and depression in dermatological patients with systemic scleroderma. Br J Dermatol 166(2):343–353
Medsger TA (2003) Natural history of systemic sclerosis and the assesment of disease activity, severity, functional status, and psychologic well-being. Rheum Dis Clin North Am 29:255–273
Nietert PJ, Mitchell HC, Bolster MB, Curran MY, Silver RM (2004) How do functional status and gastrointestinal dysfunction influence depression among patients with systemic sclerosis? Arthritis Rheum 50(9):S1174
Hamilton M (1969) Diagnosis and rating of anxiety. Br J Psychiatry 3:76–79 (Special publication)
Zung WWK (1971) A rating instrument for anxiety disorders. Psychosomatics 12:371–379
Nguyen C, Bérezné A, Baubet T, Mestre-Stanislas C, Rannou F, Papelard A, Morell-Dubois S, Revel M, Guillevin L, Poiraudeau S, Mouthon L, Groupe Français de Recherche sur la Sclérodermie (2011) Association of gender with clinical expression, quality of life, disability, and depression and anxiety in patients with systemic sclerosis. PLoS One 6(3):e17551
Bérezné A, Seror R, Morell-Dubois S, de Menthon M, Fois E, Dzeing-Ella A, Nguyen C, Hachulla E, Guillevin L, Poiraudeau S, Mouthon L (2011) Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers. Arthritis Care Res (Hoboken) 63(2):277–285. doi:10.1002/acr.20342
van Lankveld WG, Vonk MC, Teunissen H, van den Hoogen FH (2007) Appearance self-esteem in systemic sclerosis—subjective experience of skin deformity and its relationship with physician-assessed skin involvement, disease status and psychological variables. Rheumatology (Oxford) 46(5):872–876
Caine TM, Foulds GA, Hope K (1967) Manual of the Hostility and Direction of Hostility Questionnaire. University of London Press, London
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Leon, L., Abasolo, L., Redondo, M. et al. Negative affect in systemic sclerosis. Rheumatol Int 34, 597–604 (2014). https://doi.org/10.1007/s00296-013-2852-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-013-2852-7